APOE and Alzheimer disease: Specifically applied to two AD-vulnerable brain regions (middle temporal gyrus (MTG) and dorsolateral prefrontal cortex (DLPFC)), scFUMES prioritized genetics-informed metabolite-sensor networks tied to AD severity, sex differences, and APOE genotype combined with Mendelian randomization (MR).